Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034425

President and CEO sold 8,313 shares at $14.55 ($120,954)

From the SEC's structured data for this filing

Trades in this filing

Touchon Pascal · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Sale : show line 1 in the form −8,313 $14.55 $120,954 359,308 D
Open-market sales · 8,313 sh · avg $14.55 · $120,954
Loading xslF345X03/doc4.xml…